Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs (ETRALL)

This study has been completed.
Sponsor:
Collaborator:
Janssen-Cilag A.G., Switzerland
Information provided by (Responsible Party):
Calmy Alexandra, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT01543035
First received: February 27, 2012
Last updated: December 11, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)